In short. Rebound darkening, not incomplete clearing, is the outcome that decides whether melasma treatment was worth having. What provokes it and how it is avoided.

Key points

  • Treatment that is too aggressive for the skin it is applied to, sessions placed too close together, treating skin that is already inflamed, treating when the melasma is active, and continuing a course that is not working.
  • In each case the skin is being asked to absorb more irritation than it can settle, and the pigment cells respond by producing more pigment.

Most pages about melasma treatment start with how much pigment can be cleared. This one starts with the outcome that decides whether treatment was worth having, and it is not incomplete clearing. It is the skin ending up darker than it started.

Why melasma reacts to treatment

Melasma is not simply a patch of excess pigment sitting in otherwise ordinary skin. The pigment-producing cells in the affected area are over-responsive, and one of the things they respond to is inflammation. Both a low-energy laser and a chemical peel work by creating a controlled injury, which is precisely an inflammation. The same mechanism that makes the treatment effective is the mechanism that can make the condition worse.

What follows from that is a treatment philosophy rather than a technique. Settings are kept low, sessions are spaced so the skin settles, a small area is tested before the face is treated, and the course has a defined end. Each of those is a way of keeping the inflammation below the threshold that provokes the pigment.

What provokes rebound

Treatment that is too aggressive for the skin it is applied to, sessions placed too close together, treating skin that is already inflamed, treating when the melasma is active, and continuing a course that is not working. In each case the skin is being asked to absorb more irritation than it can settle, and the pigment cells respond by producing more pigment.

Why it is worse than doing nothing

Clearing that is incomplete leaves a patient where they started. Rebound leaves them somewhere worse: the pigment is deeper, it is more resistant to the treatments that might have helped, and the skin is more reactive than it was. Settling it takes months of protection and topical care rather than a further procedure. That asymmetry is the whole reason this comparison puts risk before benefit, and it is why the safest treatment for active melasma is often no procedure at all.

Warning signs that a course should stop

  • The treated area is getting darker rather than lighter after a session has settled.
  • The skin stays red, stings or feels reactive between sessions rather than returning to normal.
  • The plan is extended each time you attend, rather than reviewed against what the skin has done.

Rebound is also the reason the two routes are compared at such low intensity. A comparison between a laser and a peel for melasma is not a comparison between two ways of clearing pigment quickly; it is a comparison between two ways of clearing a small amount of pigment while provoking as little as possible. Judged that way, a gentler option that produces a modest lightening is a better plan than a stronger one that produces more.

Ask before you start what would make the course stop, and who decides. A clinician who can answer that specifically has treated melasma before. A clinic whose answer is that results take time is describing a course that has no stopping rule.

Related reading

Frequently asked questions

What exactly is rebound darkening?

It is the pigment becoming darker and more stubborn after a treatment that inflamed the skin. Melasma-prone pigment cells respond to inflammation by producing more pigment, so a course that irritates the skin can leave the affected area deeper in colour than it was before. It tends to take months to settle, and further treatment during that period usually makes it worse rather than better.

Is rebound common, or is it a rare complication?

It is common enough to be the main planning consideration rather than a rare accident. That is why melasma is treated at low settings, in spaced sessions, after a test spot, and with a clear point at which the course stops. A patient who is offered a short, intensive course for melasma is being offered the approach most likely to provoke it.

If rebound happens, what should I do?

Stop treating, treat the barrier gently, protect the skin every day and wait. Topical pigment treatment and sun protection are the mainstays, and further energy-based treatment during an active rebound usually deepens the problem. It is a slow process, and a clinician who offers an immediate corrective course has not understood what caused the darkening.

Risks & Limitations

  • Rebound darkening. Melasma-prone skin produces more pigment in response to inflammation, and both a laser and a peel create inflammation deliberately.
  • Blistering, crusting or a burn if the settings or the contact time do not match the skin, with a small risk of scarring.
  • Post-inflammatory pigment change in either direction, darker in most cases and lighter in some.
  • Infection in skin that has been broken, and uneven peeling after a chemical agent.
  • An allergic reaction to the peeling agent, which is a reason a test spot comes first.
  • Increased sun sensitivity after either route, while the skin is settling and afterwards.
  • Melasma is a tendency, not a lesion. Neither route removes it, both are followed by maintenance, and the pigment usually returns.
  • No outcome is guaranteed, and individual response varies with the depth of the pigment, the skin type and how consistently the skin is protected.

When to Seek Care

  • Blistering, crusting or a burn in the treated area — contact the treating team the same day.
  • The treated area becoming darker rather than lighter after a session has settled.
  • Spreading redness, swelling, pain or discharge, or a fever.
  • Skin that stays red, stings or feels reactive between sessions rather than returning to normal.
  • A dark patch that is new, changing in size, shape or colour, bleeding or failing to heal — seek assessment rather than treatment.
  • Difficulty breathing, or swelling of the lips, tongue or throat after a chemical peel — seek emergency care immediately.

References & Further Reading

  • American Academy of Dermatology Association (AAD) — patient information on melasma and pigmentary disorders
  • British Association of Dermatologists (BAD) — guidance on laser and light therapy and on chemical peels
  • National Institute for Health and Care Excellence (NICE, UK) — relevant guidance on skin lesions and referral
  • Cochrane Library — systematic reviews in the treatment of melasma

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.